203 related articles for article (PubMed ID: 18386173)
1. Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression.
Nieves-Alicea R; Colburn NH; Simeone AM; Tari AM
Breast Cancer Res Treat; 2009 Mar; 114(2):203-9. PubMed ID: 18386173
[TBL] [Abstract][Full Text] [Related]
2. Programmed cell death 4 inhibits leptin-induced breast cancer cell invasion.
González-Villasana V; Nieves-Alicea R; McMurtry V; Gutiérrez-Puente Y; Tari AM
Oncol Rep; 2012 Mar; 27(3):861-6. PubMed ID: 22200873
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells.
Simeone AM; Nieves-Alicea R; McMurtry VC; Colella S; Krahe R; Tari AM
Int J Oncol; 2007 Apr; 30(4):785-92. PubMed ID: 17332916
[TBL] [Abstract][Full Text] [Related]
4. Inflammation-induced loss of Pdcd4 is mediated by phosphorylation-dependent degradation.
Schmid T; Bajer MM; Blees JS; Eifler LK; Milke L; Rübsamen D; Schulz K; Weigert A; Baker AR; Colburn NH; Brüne B
Carcinogenesis; 2011 Oct; 32(10):1427-33. PubMed ID: 21771721
[TBL] [Abstract][Full Text] [Related]
5. FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells.
Dikshit B; Irshad K; Madan E; Aggarwal N; Sarkar C; Chandra PS; Gupta DK; Chattopadhyay P; Sinha S; Chosdol K
Oncogene; 2013 Aug; 32(33):3798-808. PubMed ID: 22986533
[TBL] [Abstract][Full Text] [Related]
6. Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion.
Santhanam AN; Baker AR; Hegamyer G; Kirschmann DA; Colburn NH
Oncogene; 2010 Jul; 29(27):3921-32. PubMed ID: 20498644
[TBL] [Abstract][Full Text] [Related]
7. Radiation-enhancement of MDA-MB-231 breast cancer cell invasion prevented by a cyclooxygenase-2 inhibitor.
Paquette B; Therriault H; Desmarais G; Wagner R; Royer R; Bujold R
Br J Cancer; 2011 Aug; 105(4):534-41. PubMed ID: 21792195
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells.
Kang JH; Song KH; Jeong KC; Kim S; Choi C; Lee CH; Oh SH
BMC Cancer; 2011 Aug; 11():334. PubMed ID: 21813027
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.
Asangani IA; Rasheed SA; Nikolova DA; Leupold JH; Colburn NH; Post S; Allgayer H
Oncogene; 2008 Apr; 27(15):2128-36. PubMed ID: 17968323
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.
Chen Z; Yuan YC; Wang Y; Liu Z; Chan HJ; Chen S
Breast Cancer Res Treat; 2015 Jul; 152(1):29-39. PubMed ID: 26026468
[TBL] [Abstract][Full Text] [Related]
11. Inflammation and MiR-21 pathways functionally interact to downregulate PDCD4 in colorectal cancer.
Peacock O; Lee AC; Cameron F; Tarbox R; Vafadar-Isfahani N; Tufarelli C; Lund JN
PLoS One; 2014; 9(10):e110267. PubMed ID: 25310697
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4.
Yang Y; Meng H; Peng Q; Yang X; Gan R; Zhao L; Chen Z; Lu J; Meng QH
Cancer Gene Ther; 2015 Jan; 22(1):23-9. PubMed ID: 25477028
[TBL] [Abstract][Full Text] [Related]
13. Targeting of COX-2 expression by recombinant adenovirus shRNA attenuates the malignant biological behavior of breast cancer cells.
Tu B; Ma TT; Peng XQ; Wang Q; Yang H; Huang XL
Asian Pac J Cancer Prev; 2014; 15(20):8829-36. PubMed ID: 25374215
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer cells induce osteoclast formation by stimulating host IL-11 production and downregulating granulocyte/macrophage colony-stimulating factor.
Morgan H; Tumber A; Hill PA
Int J Cancer; 2004 May; 109(5):653-60. PubMed ID: 14999770
[TBL] [Abstract][Full Text] [Related]
15. NDRG2 controls COX-2/PGE₂-mediated breast cancer cell migration and invasion.
Kim MJ; Kim HS; Lee SH; Yang Y; Lee MS; Lim JS
Mol Cells; 2014 Oct; 37(10):759-65. PubMed ID: 25256221
[TBL] [Abstract][Full Text] [Related]
16. Sanguinarine inhibits invasiveness and the MMP-9 and COX-2 expression in TPA-induced breast cancer cells by inducing HO-1 expression.
Park SY; Jin ML; Kim YH; Lee SJ; Park G
Oncol Rep; 2014 Jan; 31(1):497-504. PubMed ID: 24220687
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.
Zhu S; Wu H; Wu F; Nie D; Sheng S; Mo YY
Cell Res; 2008 Mar; 18(3):350-9. PubMed ID: 18270520
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis.
Badawi AF; Badr MZ
Int J Cancer; 2003 Jan; 103(1):84-90. PubMed ID: 12455057
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-specific protease 4 inhibits breast cancer cell growth through the upregulation of PDCD4.
Li Y; Jiang D; Zhang Q; Liu X; Cai Z
Int J Mol Med; 2016 Sep; 38(3):803-11. PubMed ID: 27430936
[TBL] [Abstract][Full Text] [Related]
20. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]